Case study · Industrial cases
Unlocking gene therapy with DataHowLab
Highlights from industrial cases show how DataHowLab delivers development insight for gene therapy bioprocesses despite limited, costly data.
-
12
Experiments were enough to predict final CQAs
-
3
Bioprocess phases mapped for variable importance: growth, perfusion and transfection
-
2
Historical gene therapy bioprocesses added to training reduced prediction error
The challenge
CQAs measured only at the end
Gene therapy bioprocesses are complex and sequential, while CQAs are typically measured only at the end. Issues surface late, leading to failed batches, and high experimental costs limit the data available.
The approach
Hybrid models and transfer learning
DataHowLab was assessed on predicting final CQAs from limited data, generating insight across each phase to support a sequential control strategy, and using historical projects to improve insight for new developments.
- 3 industrial cases
- RMSE accuracy metric
- End of bioprocess CQA measurement
Get the full results
Download the full case study, with project outline, analysis, and case results.